Magnetically Controlled Capsule Endoscopy (MCE) is an innovative, noninvasive diagnostic technology designed to evaluate gastric conditions as an alternative to the traditional esophagogastroduodenoscopy (EGD). EGD, although highly accurate, is an invasive procedure requiring sedation and the insertion of an endoscope, which can cause discomfort and potential risks for patients. MCE, on the other hand, involves swallowing a small capsule equipped with a camera that captures high-resolution images of the gastrointestinal tract. The capsule's movement is controlled externally using magnetic fields, allowing for thorough visualization of gastric anatomy without the need for invasive intervention.
A recent review aimed to assess the diagnostic accuracy of MCE compared to EGD, which is considered the gold standard for detecting gastric conditions. The analysis included ten studies with a total of 1,667 diagnostic units, and the findings demonstrated that MCE has a high diagnostic accuracy. The pooled sensitivity and specificity of MCE were both 0.92, indicating its ability to correctly identify both the presence and absence of gastric abnormalities. The area under the receiver operating characteristic curve (AUC) was 0.96, reflecting excellent diagnostic performance. Furthermore, the diagnostic odds ratio (DOR) of 129 suggests that MCE is highly effective at distinguishing between diseased and non-diseased states.
Despite its promising results, substantial heterogeneity (I² = 97%) was observed across studies, particularly in specificity, highlighting the need for further standardization and research. MCE offers significant potential as a noninvasive alternative to EGD, especially for patients who cannot tolerate traditional endoscopy. Future studies should focus on optimizing its clinical application, addressing interstudy variability, and evaluating its cost-effectiveness to establish its role in routine clinical practice.